Sign In
Buy HQL
$18.63
+0.290 (+1.58%)
At Close: Jun 23, 2026
The 39 Best Valentine’s Day Gifts Over $100
04:56pm, Monday, 10'th Feb 2020
From fragrances to watches to a hair dryer they won't be able to put down, these luxury gifts go all the way — and then some.
Should Investors Avoid U.S. Healthcare Stocks In An Election Year?
02:35pm, Monday, 10'th Feb 2020
US healthcare is always a political hot potato, and volatility is expected to rise as the November elections approach. The US healthcare sector traded at a pric
100+ Valentine’s Day Gift Ideas for Every Budget
09:00am, Monday, 10'th Feb 2020
It's always smart to set a budget when you're shopping for a gift. Our list offers up the best Valentine's Day gifts at major price points so you can find a great gift for that special someone.
Cwm LLC Acquires New Position in Tekla Life Sciences Investors (NYSE:HQL)
09:08am, Tuesday, 04'th Feb 2020
Cwm LLC acquired a new stake in Tekla Life Sciences Investors (NYSE:HQL) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC)
Tekla Healthcare Opportunities Fund Paid Distribution
03:29pm, Friday, 31'st Jan 2020
On January 31, 2020, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from return of capital or other c
Doliver Advisors LP Buys 10,048 Shares of Tekla Life Sciences Investors (NYSE:HQL)
11:02am, Tuesday, 28'th Jan 2020
Doliver Advisors LP increased its stake in shares of Tekla Life Sciences Investors (NYSE:HQL) by 59.7% during the 4th quarter, HoldingsChannel.com reports. The firm owned 26,870 shares of the company�
NEXT Financial Group Inc Grows Position in Tekla Life Sciences Investors (NYSE:HQL)
09:52am, Sunday, 26'th Jan 2020
NEXT Financial Group Inc increased its position in shares of Tekla Life Sciences Investors (NYSE:HQL) by 32.8% during the fourth quarter, Holdings Channel reports. The institutional investor owned 18,
Top Picks 2020- Tekla Life Sciences Fund HQL
10:00am, Thursday, 23'rd Jan 2020
Tekla Life Sciences Fund (HQL) frequently makes the cut as my Top Pick for more conservative investors -- thanks to its generous distribution policy, explains Nate Pile, editor of Nate's Notes.
EQRx's Challenge, And My Challenge To Them
01:15pm, Thursday, 16'th Jan 2020
EQRx's plan is apparently to come up with new competing pharmaceuticals in existing categories and sell them for lower prices than the patented ones. Insurance
HQL: Healthcare Offers A Defensive Play For A Volatile Market With Solid Growth Potential
12:00am, Thursday, 08'th Aug 2019The Chemist's Closed-End Fund Report - April 2019: Treading Water
04:16pm, Tuesday, 07'th May 2019
No summary available.
Weekly Closed-End Fund Roundup: DSU Tender Results, Some CEF High Fliers Lose Air
02:56pm, Monday, 06'th May 2019
No summary available.
Weekly Closed-End Fund Roundup: FAX Cuts Big, NHF Rights Offering Announced
03:41pm, Tuesday, 30'th Apr 2019
No summary available.
